Home » Healthcare » Pharmaceuticals » Influenza Therapeutics Market

Influenza Therapeutics Market By Therapy Type (Vaccines, Drugs) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Price: $4999

Published: | Report ID: 6565 | Report Format : PDF

Market Insights

The global influenza therapeutics market is anticipated to grow significantly during the forecast period due to the growing prevalence of influenza, increasing demand for treatment medication, and government initiatives in awareness and treatment that will drive the growth of the influenza therapeutics market globally.

The report titled “Influenza Therapeutics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall influenza therapeutics market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on technology and different geographical regions.

Geographically, the global influenza therapeutics market is studied for the following regional markets:

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global influenza therapeutics market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global influenza therapeutics market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global influenza therapeutics market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global influenza therapeutics market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on therapy type, the global influenza therapeutics market is segmented as follows:

  • Vaccines
  • Trivalent
  • Quadrivalent
  • Drugs
  • Zanamivir
  • Oseltamivir
  • Peramivir
  • Other

Influenza is an acute respiratory disease caused by influenza A, B or C virus infection; it is preventable by vaccination or chemoprophylaxis and is treatable by specific antiviral drugs. The World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000 and 500,000 deaths. Currently, influenza vaccines (also known as flu shots or jabs) dominate the global influenza market because government initiative for vaccination is a prime factor driving the growth of the influenza vaccine market globally. The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and European Centre for Disease Prevention and Control recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. For the treatment of influenza, the CDC recommends oral oseltamivir (Tamiflu), inhaled zanamivir (Relenza), and intravenous peramivir (Rapivab) antiviral medications, as well as trivalent and quadrivalent vaccines; all of these factors are contributing to the global influenza market’s growth.

For the purpose of this study, the global influenza therapeutics market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000 and 500,000 deaths due to influenza infection. It is observed that, currently, North America is followed by Europe in dominating the global influenza market because government initiatives such as the Centers for Disease Control and Prevention (CDC) and the European Centre for Disease Prevention and Control recommend yearly influenza vaccination for nearly all people over the age of six months, especially those at high risk, which are primarily driving the growth of the influenza market in these regions. Also, some factors, such as the growing incidence of infectious diseases, higher healthcare awareness, and an aging population, are fueling market growth in developed regions. On the other hand, Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the higher number of targeted populations, rising healthcare awareness, and government initiatives in the prevention of infectious diseases that would assist the market growth during the forecast period in that region.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Influenza Therapeutics Market Snapshot
2.2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
2.3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)

Chapter 3 Influenza Therapeutics Market Analysis
3.1 Global Influenza Therapeutics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in prevalence of Influenza
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Pipeline Analysis
3.4 Attractive Investment Proposition
3.5 Competitive Landscape of Key Players in Influenza Market

Chapter 4 Global Influenza Therapeutics Market, by Therapy Type
4.1 Overview
4.3 Vaccines
4.4 Drugs

Chapter 5 Global Influenza Therapeutics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Astrazeneca PLC
6.3 Biocryst Pharmaceuticals, Inc.
6.4 Chiron Corporation
6.5 CSL Limited
6.6 Daiichi Sankyo Co., Ltd.
6.7 Glaxosmithkline PLC
6.8 Mitsubishi Tanabe Pharma Corporation
6.9 Nanotherapeutics Inc.
6.10 Protein Sciences Corporation
6.11 Roche Holding AG
6.12 Sanofi SA
6.13 Shionogi & Co., Ltd.
6.14 Sinovac Biotech Ltd.

List of Figures

FIG. 1 Influenza Therapeutics Market: Research Methodology
FIG. 2 Global Influenza Therapeutics Market, by Therapy Type, 2016 (US$ Mn)
FIG. 3 Global Influenza Therapeutics Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Influenza Therapeutics Market, by Geography, 2016
FIG. 5 Global Vaccines Market for Influenza Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 6 Global Drugs Market for Influenza Therapeutics, 2015 – 2025 (US$ Mn)
FIG. 7 Latin America Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
FIG. 8 Middle East and Africa Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Influenza Therapeutics Market
TABLE 2 Global Influenza Therapeutics Market, by Therapy Type, 2015 – 2025 (US$ Mn)
TABLE 3 Global Influenza Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 6 Asia Pacific Influenza Therapeutics Market, 2015 – 2025 (US$ Mn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Astrazeneca PLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Biocryst Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Chiron Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 CSL Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Daiichi Sankyo Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Glaxosmithkline PLC : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Mitsubishi Tanabe Pharma Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Nanotherapeutics Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Protein Sciences Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Roche Holding AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Sanofi SA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Shionogi & Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Sinovac Biotech Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Influenza Therapeutics Market?

The market for Influenza Therapeutics is expected to reach US$ 1204.1 Mn in 2025.

What is the Influenza Therapeutics Market CAGR?

The Influenza Therapeutics market is expected to see significant CAGR growth over the coming years, at 7.8%.

What is the Forecast period considered for Influenza Therapeutics Market?

The report is forecasted from 2015-2025.

What is the base year considered for Influenza Therapeutics Market?

The base year of this report is 2014.

Who are the major players in this market?

Abbott Laboratories,Astrazeneca PLC,Biocryst Pharmaceuticals, Inc.,Chiron Corporation,CSL Limited are some of the major players in the global market.

Inulin Market

Published:
Report ID: 11192

Drug Discovery Market

Published:
Report ID: 38270

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Japan’s Pharmacy Automation Market

Published:
Report ID: 37511

Sterile Active Pharmaceutical Ingredient Market

Published:
Report ID: 37476

Organ Preservation Solutions Market

Published:
Report ID: 37472

Middle East and Africa Veterinary Vaccines Market

Published:
Report ID: 37309

Asia Pacific Stem Cell Therapy Market

Published:
Report ID: 37280

US Active Pharmaceutical Ingredient (API) Market

Published:
Report ID: 37221

Cancer Supportive Care Market

Published:
Report ID: 1901

Middle East and Africa Radiopharmaceuticals Market

Published:
Report ID: 37164

Temperature Controlled Pharma Packaging Solutions Market

Published:
Report ID: 20599

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN